Bayer and Janssen’s Xarelto shows promising results in reducing blood clot recurrence
Bayer AG and Janssen Pharmaceuticals, two giants in the pharmaceutical industry, have announced significant findings from their EINSTEIN CHOICE clinical trial, showcasing the effectiveness of ... Read More